EV/EBITDA
-9.72
+0.25+2.51%
10 min ago
Summary
- As of February 7, 2025, ELVN EV/EBITDA is -9.72, with a rise of +0.25 (+2.51%) during the most recent trading day.
- Over the past year, ELVN EV/EBITDA has dropped by -3.37 (-53.07%).
- ELVN EV/EBITDA is now -155.79% below its all-time high of -3.80.
Performance
ELVN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ELVN EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +2.5% | -2.5% | -2.3% |
1 m1 month | +8.7% | -8.7% | -8.0% |
3 m3 months | +26.1% | -26.1% | -24.3% |
6 m6 months | -2.0% | +4.9% | +1.3% |
ytdytd | +2.6% | -2.6% | -2.4% |
1 y1 year | -53.1% | +83.9% | +44.3% |
5 y5 years | - | - | - |
ELVN EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -8.6% | -10.79 | +9.9% | |
3 m | 3-month | -8.95 | -8.6% | -13.42 | +27.6% |
6 m | 6-month | -8.72 | -11.5% | -13.42 | +27.6% |
1 y | 1-year | -3.80 | -155.8% | -13.42 | +27.6% |
3 y | 3-year | -3.80 | -155.8% | -23.53 | +58.7% |
5 y | 5-year | -3.80 | -155.8% | -23.53 | +58.7% |
alltime | all time | -3.80 | -155.8% | -23.53 | +58.7% |
Enliven Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | -9.72(-2.6%) |
Date | Value |
---|---|
2024 | -9.98(+70.6%) |
2023 | -5.85 |
FAQ
- What is Enliven Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Enliven Therapeutics?
- What is ELVN EV/EBITDA year-to-date change?
- What is Enliven Therapeutics EV/EBITDA year-on-year change?
What is Enliven Therapeutics EV/EBITDA?
The current EV/EBITDA of ELVN is -9.72
What is the all time high EV/EBITDA for Enliven Therapeutics?
Enliven Therapeutics all-time high EV/EBITDA is -3.80
What is ELVN EV/EBITDA year-to-date change?
Enliven Therapeutics EV/EBITDA has changed by +0.26 (+2.61%) since the beginning of the year
What is Enliven Therapeutics EV/EBITDA year-on-year change?
Over the past year, ELVN EV/EBITDA has changed by -3.37 (-53.07%)